Dexamethasone protects against tourniquet-induced acute ischemia-reperfusion injury in mouse hindlimb

Ryan M. Corrick, Huiyin Tu, Dongze Zhang, Aaron N Barksdale, Robert Leo Muelleman, Michael Charles Wadman, Yulong Li

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Extremity injuries with hemorrhage have been a significant cause of death in civilian medicine and on the battlefield. The use of a tourniquet as an intervention is necessary for treatment to an injured limb; however, the tourniquet and subsequent release results in serious acute ischemia-reperfusion (IR) injury in the skeletal muscle and neuromuscular junction (NMJ). Much evidence demonstrates that inflammation is an important factor to cause acute IR injury. To find effective therapeutic interventions for tourniquet-induced acute IR injuries, our current study investigated effect of dexamethasone, an anti-inflammatory drug, on tourniquet-induced acute IR injury in mouse hindlimb. In C57/BL6 mice, a tourniquet was placed on unilateral hindlimb (left hindlimb) at the hip joint for 3 h, and then released for 24 h to induce IR. Three hours of tourniquet and 24 h of release (24-h IR) caused gastrocnemius muscle injuries including rupture of the muscle sarcolemma and necrosis (42.8 ± 2.3% for infarct size of the gastrocnemius muscle). In the NMJ, motor nerve terminals disappeared, and endplate potentials were undetectable in 24-h IR mice. There was no gastrocnemius muscle contraction in 24-h IR mice. Western blot data showed that inflammatory cytokines (TNFa and IL-1ß) were increased in the gastrocnemius muscle after 24-h IR. Treatment with dexamethasone at the beginning of reperfusion (1 mg/kg, i.p.) significantly inhibited expression of TNFa and IL-1ß, reduced rupture of the muscle sarcolemma and infarct size (24.8 ± 2.0%), and improved direct muscle stimulation-induced gastrocnemius muscle contraction in 24-h IR mice. However, this anti-inflammatory drug did not improve NMJ morphology and function, and sciatic nerve-stimulated skeletal muscle contraction in 24-h IR mice. The data suggest that one-time treatment with dexamethasone at the beginning of reperfusion only reduced structural and functional impairments of the skeletal muscle but not the NMJ through inhibiting inflammatory cytokines.

Original languageEnglish (US)
Article number244
JournalFrontiers in Physiology
Volume9
Issue numberMAR
DOIs
StatePublished - Mar 20 2018

Fingerprint

Tourniquets
Hindlimb
Reperfusion Injury
Dexamethasone
Reperfusion
Skeletal Muscle
Ischemia
Neuromuscular Junction
Muscle Contraction
Sarcolemma
Interleukin-1
Muscles
Rupture
Anti-Inflammatory Agents
Extremities
Cytokines
Hip Joint
Wounds and Injuries
Sciatic Nerve
Pharmaceutical Preparations

Keywords

  • Acute ischemia-reperfusion injury
  • Cytokine
  • Dexamethasone
  • Neuromuscular junction
  • Skeletal muscle
  • tourniquet

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

Dexamethasone protects against tourniquet-induced acute ischemia-reperfusion injury in mouse hindlimb. / Corrick, Ryan M.; Tu, Huiyin; Zhang, Dongze; Barksdale, Aaron N; Muelleman, Robert Leo; Wadman, Michael Charles; Li, Yulong.

In: Frontiers in Physiology, Vol. 9, No. MAR, 244, 20.03.2018.

Research output: Contribution to journalArticle

@article{689bcc1033614e77a33186e96994bf26,
title = "Dexamethasone protects against tourniquet-induced acute ischemia-reperfusion injury in mouse hindlimb",
abstract = "Extremity injuries with hemorrhage have been a significant cause of death in civilian medicine and on the battlefield. The use of a tourniquet as an intervention is necessary for treatment to an injured limb; however, the tourniquet and subsequent release results in serious acute ischemia-reperfusion (IR) injury in the skeletal muscle and neuromuscular junction (NMJ). Much evidence demonstrates that inflammation is an important factor to cause acute IR injury. To find effective therapeutic interventions for tourniquet-induced acute IR injuries, our current study investigated effect of dexamethasone, an anti-inflammatory drug, on tourniquet-induced acute IR injury in mouse hindlimb. In C57/BL6 mice, a tourniquet was placed on unilateral hindlimb (left hindlimb) at the hip joint for 3 h, and then released for 24 h to induce IR. Three hours of tourniquet and 24 h of release (24-h IR) caused gastrocnemius muscle injuries including rupture of the muscle sarcolemma and necrosis (42.8 ± 2.3{\%} for infarct size of the gastrocnemius muscle). In the NMJ, motor nerve terminals disappeared, and endplate potentials were undetectable in 24-h IR mice. There was no gastrocnemius muscle contraction in 24-h IR mice. Western blot data showed that inflammatory cytokines (TNFa and IL-1{\ss}) were increased in the gastrocnemius muscle after 24-h IR. Treatment with dexamethasone at the beginning of reperfusion (1 mg/kg, i.p.) significantly inhibited expression of TNFa and IL-1{\ss}, reduced rupture of the muscle sarcolemma and infarct size (24.8 ± 2.0{\%}), and improved direct muscle stimulation-induced gastrocnemius muscle contraction in 24-h IR mice. However, this anti-inflammatory drug did not improve NMJ morphology and function, and sciatic nerve-stimulated skeletal muscle contraction in 24-h IR mice. The data suggest that one-time treatment with dexamethasone at the beginning of reperfusion only reduced structural and functional impairments of the skeletal muscle but not the NMJ through inhibiting inflammatory cytokines.",
keywords = "Acute ischemia-reperfusion injury, Cytokine, Dexamethasone, Neuromuscular junction, Skeletal muscle, tourniquet",
author = "Corrick, {Ryan M.} and Huiyin Tu and Dongze Zhang and Barksdale, {Aaron N} and Muelleman, {Robert Leo} and Wadman, {Michael Charles} and Yulong Li",
year = "2018",
month = "3",
day = "20",
doi = "10.3389/fphys.2018.00244",
language = "English (US)",
volume = "9",
journal = "Frontiers in Physiology",
issn = "1664-042X",
publisher = "Frontiers Research Foundation",
number = "MAR",

}

TY - JOUR

T1 - Dexamethasone protects against tourniquet-induced acute ischemia-reperfusion injury in mouse hindlimb

AU - Corrick, Ryan M.

AU - Tu, Huiyin

AU - Zhang, Dongze

AU - Barksdale, Aaron N

AU - Muelleman, Robert Leo

AU - Wadman, Michael Charles

AU - Li, Yulong

PY - 2018/3/20

Y1 - 2018/3/20

N2 - Extremity injuries with hemorrhage have been a significant cause of death in civilian medicine and on the battlefield. The use of a tourniquet as an intervention is necessary for treatment to an injured limb; however, the tourniquet and subsequent release results in serious acute ischemia-reperfusion (IR) injury in the skeletal muscle and neuromuscular junction (NMJ). Much evidence demonstrates that inflammation is an important factor to cause acute IR injury. To find effective therapeutic interventions for tourniquet-induced acute IR injuries, our current study investigated effect of dexamethasone, an anti-inflammatory drug, on tourniquet-induced acute IR injury in mouse hindlimb. In C57/BL6 mice, a tourniquet was placed on unilateral hindlimb (left hindlimb) at the hip joint for 3 h, and then released for 24 h to induce IR. Three hours of tourniquet and 24 h of release (24-h IR) caused gastrocnemius muscle injuries including rupture of the muscle sarcolemma and necrosis (42.8 ± 2.3% for infarct size of the gastrocnemius muscle). In the NMJ, motor nerve terminals disappeared, and endplate potentials were undetectable in 24-h IR mice. There was no gastrocnemius muscle contraction in 24-h IR mice. Western blot data showed that inflammatory cytokines (TNFa and IL-1ß) were increased in the gastrocnemius muscle after 24-h IR. Treatment with dexamethasone at the beginning of reperfusion (1 mg/kg, i.p.) significantly inhibited expression of TNFa and IL-1ß, reduced rupture of the muscle sarcolemma and infarct size (24.8 ± 2.0%), and improved direct muscle stimulation-induced gastrocnemius muscle contraction in 24-h IR mice. However, this anti-inflammatory drug did not improve NMJ morphology and function, and sciatic nerve-stimulated skeletal muscle contraction in 24-h IR mice. The data suggest that one-time treatment with dexamethasone at the beginning of reperfusion only reduced structural and functional impairments of the skeletal muscle but not the NMJ through inhibiting inflammatory cytokines.

AB - Extremity injuries with hemorrhage have been a significant cause of death in civilian medicine and on the battlefield. The use of a tourniquet as an intervention is necessary for treatment to an injured limb; however, the tourniquet and subsequent release results in serious acute ischemia-reperfusion (IR) injury in the skeletal muscle and neuromuscular junction (NMJ). Much evidence demonstrates that inflammation is an important factor to cause acute IR injury. To find effective therapeutic interventions for tourniquet-induced acute IR injuries, our current study investigated effect of dexamethasone, an anti-inflammatory drug, on tourniquet-induced acute IR injury in mouse hindlimb. In C57/BL6 mice, a tourniquet was placed on unilateral hindlimb (left hindlimb) at the hip joint for 3 h, and then released for 24 h to induce IR. Three hours of tourniquet and 24 h of release (24-h IR) caused gastrocnemius muscle injuries including rupture of the muscle sarcolemma and necrosis (42.8 ± 2.3% for infarct size of the gastrocnemius muscle). In the NMJ, motor nerve terminals disappeared, and endplate potentials were undetectable in 24-h IR mice. There was no gastrocnemius muscle contraction in 24-h IR mice. Western blot data showed that inflammatory cytokines (TNFa and IL-1ß) were increased in the gastrocnemius muscle after 24-h IR. Treatment with dexamethasone at the beginning of reperfusion (1 mg/kg, i.p.) significantly inhibited expression of TNFa and IL-1ß, reduced rupture of the muscle sarcolemma and infarct size (24.8 ± 2.0%), and improved direct muscle stimulation-induced gastrocnemius muscle contraction in 24-h IR mice. However, this anti-inflammatory drug did not improve NMJ morphology and function, and sciatic nerve-stimulated skeletal muscle contraction in 24-h IR mice. The data suggest that one-time treatment with dexamethasone at the beginning of reperfusion only reduced structural and functional impairments of the skeletal muscle but not the NMJ through inhibiting inflammatory cytokines.

KW - Acute ischemia-reperfusion injury

KW - Cytokine

KW - Dexamethasone

KW - Neuromuscular junction

KW - Skeletal muscle

KW - tourniquet

UR - http://www.scopus.com/inward/record.url?scp=85044307544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044307544&partnerID=8YFLogxK

U2 - 10.3389/fphys.2018.00244

DO - 10.3389/fphys.2018.00244

M3 - Article

C2 - 29615933

AN - SCOPUS:85044307544

VL - 9

JO - Frontiers in Physiology

JF - Frontiers in Physiology

SN - 1664-042X

IS - MAR

M1 - 244

ER -